Research progress of paclitaxel drug formulations / 中国基层医药

ABSTRACT

Paclitaxel is an antimicrotubule agent indicated as first-line therapy for the treatment of advanced carcinoma of the ovary and breast cancer.Oral administration of paclitaxel is preferred as it is convenient to use in hospital and reduces costs.However,due to the low oral bioavailability of paclitaxel,most commercially available for-mulations are injections.This review presents the progress of developed paclitaxel injection and oral formulations to enhance the bioavailability of paclitaxel.